GANX News

The IPO market stayed busy this past week, with 11 IPOs raising $3.0 billion. The week’s IPOs were joined by 24 SPACs that raised $8.4 billion. New filers continued to fill the IPO pipeline, with 8 IPOs and 46 SPACs submitting initial filings. Chinese IoT platform developer Tuya (TUYA) priced above the range to raise $915 million at an $11.8 billion...read more

Gain Therapeutics, a preclinical biotech developing small molecule therapies for lysosomal storage disorders, raised $40 million by offering 3.6 million shares at $11, within the range of $10 to $12. At pricing, the company commands a fully diluted market value of $129 million. Gain Therapeutics is developing novel therapies to treat diseases caused by protein misfolding,...read more

Updated Monday, 3/15. The IPO market starts to pick back up with 10 IPOs scheduled to raise $2.5 billion in the week ahead. Chinese IoT platform developer Tuya (TUYA) plans to raise $806 million at a $10.4 billion market cap. Tuya’s platform offers PaaS and SaaS to over 5,000 customers for the development, management, and monetization of...read more

Gain Therapeutics, a preclinical biotech developing small molecule therapies for lysosomal storage disorders, announced terms for its IPO on Wednesday. The Bethesda, MD-based company plans to raise $40 million by offering 3.6 million shares at a price range of $10 to $12. At the midpoint of the proposed range, Gain Therapeutics would command a fully diluted market value of $129...read more